Published in TB and Outbreaks Week, September 15th, 1997
Despite this finding, researcher Jan Sahai and colleagues do not recommend that prescribed doses of antituberculosis drugs be increased for patients infected with HIV.
"Studies of patients with active tuberculosis are urgently needed to determine the clinical and microbiological significance of our pharmacokinetic study and to evaluate therapeutic drug monitoring with dose adjustment before recommendations can be made," Sahai et al. wrote ("Reduced Plasma Concentrations of Antituberculosis Drugs...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.